volume 1271 pages 133970

Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy

Mohammed Hadi Ali Al Jumaili 1
Anas Abdullah Hamad 2
Heba E. Hashem 3
Abdulhakeem D Hussein 4
Mohammed J. Muhaidi 5
Mohammad Abdaljabbar Ahmed 6
Ali Hussein Alwan ALBANAA 6
Ekhlas Aziz Bakr 8
2
 
Department of Medical Laboratory Techniques, Al Maarif University College, Al-Anbar, Ramadi 31001, Iraq
4
 
Department of Chemistry, College of Science, University of Fallujah, Al-Anbar, Iraq
5
 
College of Applied Sciences, University of Fallujah, Al-Anbar, Iraq
8
 
Ministry of Education, Al-Anbar Administrative, Al-Anbar, Iraq
Publication typeJournal Article
Publication date2023-01-01
scimago Q2
wos Q2
SJR0.628
CiteScore8.0
Impact factor4.7
ISSN00222860, 18728014
Organic Chemistry
Inorganic Chemistry
Spectroscopy
Analytical Chemistry
Abstract
Heterocyclic compounds are one of the largest family of organic compounds with broad range of applications in medicinal chemistry and agrochemicals product. Bis-heterocycle and their families have had a significant development of new anticancer drugs according to the literature data published in recent years. Bis-heterocyclic compounds are present in various pharmaceuticals with unique physicochemical properties and have been confirmed as major pillars of medicinal chemistry. Anticancer research has been focused on these molecules' versatility and dynamic core structure. The presented review aims to summarize different bis-heterocyclic active compounds and their beneficial functions as drug targets in cancer therapy and chemoprevention.
Found 
Found 

Top-30

Journals

2
4
6
8
10
12
Journal of Molecular Structure
11 publications, 12.94%
ACS Omega
5 publications, 5.88%
ChemistrySelect
4 publications, 4.71%
Organic Letters
3 publications, 3.53%
European Journal of Organic Chemistry
3 publications, 3.53%
Molecules
2 publications, 2.35%
Journal of Chemical Research
2 publications, 2.35%
Results in Chemistry
2 publications, 2.35%
Molecular Diversity
2 publications, 2.35%
Tetrahedron
2 publications, 2.35%
Research on Chemical Intermediates
2 publications, 2.35%
RSC Advances
2 publications, 2.35%
Archiv der Pharmazie
2 publications, 2.35%
Mendeleev Communications
1 publication, 1.18%
Journal of Molecular Modeling
1 publication, 1.18%
Journal of Chemical Sciences
1 publication, 1.18%
Pharmaceutical Fronts
1 publication, 1.18%
Advances in Heterocyclic Chemistry
1 publication, 1.18%
Journal of Molecular and Engineering Materials
1 publication, 1.18%
Pharmacology and Therapeutics
1 publication, 1.18%
Bioorganic and Medicinal Chemistry
1 publication, 1.18%
Oriental Journal Of Chemistry
1 publication, 1.18%
Frontiers in Chemistry
1 publication, 1.18%
Chemical Papers
1 publication, 1.18%
European Journal of Medicinal Chemistry
1 publication, 1.18%
Current Organic Chemistry
1 publication, 1.18%
Metabolites
1 publication, 1.18%
Chemistry of Heterocyclic Compounds
1 publication, 1.18%
Mini-Reviews in Medicinal Chemistry
1 publication, 1.18%
Case Studies in Chemical and Environmental Engineering
1 publication, 1.18%
2
4
6
8
10
12

Publishers

5
10
15
20
25
Elsevier
22 publications, 25.88%
Wiley
13 publications, 15.29%
Springer Nature
11 publications, 12.94%
American Chemical Society (ACS)
9 publications, 10.59%
MDPI
5 publications, 5.88%
Royal Society of Chemistry (RSC)
5 publications, 5.88%
Taylor & Francis
4 publications, 4.71%
Pleiades Publishing
3 publications, 3.53%
Georg Thieme Verlag KG
2 publications, 2.35%
SAGE
2 publications, 2.35%
Bentham Science Publishers Ltd.
2 publications, 2.35%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.18%
World Scientific
1 publication, 1.18%
Oriental Scientific Publishing Company
1 publication, 1.18%
Frontiers Media S.A.
1 publication, 1.18%
Walter de Gruyter
1 publication, 1.18%
AIP Publishing
1 publication, 1.18%
American Association for the Advancement of Science (AAAS)
1 publication, 1.18%
5
10
15
20
25
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
85
Share
Cite this
GOST |
Cite this
GOST Copy
Al Jumaili M. H. A. et al. Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy // Journal of Molecular Structure. 2023. Vol. 1271. p. 133970.
GOST all authors (up to 50) Copy
Al Jumaili M. H. A., Hamad A. A., Hashem H. E., Hussein A. D., Muhaidi M. J., Ahmed M. A., ALBANAA A. H. A., Siddique F., Bakr E. A. Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy // Journal of Molecular Structure. 2023. Vol. 1271. p. 133970.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.molstruc.2022.133970
UR - https://doi.org/10.1016/j.molstruc.2022.133970
TI - Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy
T2 - Journal of Molecular Structure
AU - Al Jumaili, Mohammed Hadi Ali
AU - Hamad, Anas Abdullah
AU - Hashem, Heba E.
AU - Hussein, Abdulhakeem D
AU - Muhaidi, Mohammed J.
AU - Ahmed, Mohammad Abdaljabbar
AU - ALBANAA, Ali Hussein Alwan
AU - Siddique, Farhan
AU - Bakr, Ekhlas Aziz
PY - 2023
DA - 2023/01/01
PB - Elsevier
SP - 133970
VL - 1271
SN - 0022-2860
SN - 1872-8014
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Al Jumaili,
author = {Mohammed Hadi Ali Al Jumaili and Anas Abdullah Hamad and Heba E. Hashem and Abdulhakeem D Hussein and Mohammed J. Muhaidi and Mohammad Abdaljabbar Ahmed and Ali Hussein Alwan ALBANAA and Farhan Siddique and Ekhlas Aziz Bakr},
title = {Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy},
journal = {Journal of Molecular Structure},
year = {2023},
volume = {1271},
publisher = {Elsevier},
month = {jan},
url = {https://doi.org/10.1016/j.molstruc.2022.133970},
pages = {133970},
doi = {10.1016/j.molstruc.2022.133970}
}
Profiles